Novartis Venture Fund
Novartis Venture Fund invests in biotech and pharma, focusing on early to late-stage companies globally. 70+ exits via IPO or M&A, including FDA-approved drugs.
Funding Stage: Pre-Seed / Seed, Series A/B, Series C & Beyond
Investor type: VC Firm
Investment Areas: Finance, Therapeutics, Venture Capital, Life Science, Investment
Country: Switzerland
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
